Prognostic impact of FOXP3 expression in triple-negative breast cancer

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Acta oncologica

• Publication date

  2013-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/0284186X.2012.731520PMID 23075422
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FOXP3 Is an X-Linked Breast Cancer Suppressor Gene and an Important Repressor of the HER-2/ErbB2 Oncogene.

  2021cited by this paper
• BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers

  2012cited by this paper
• FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling

  2012cited by this paper
• CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes

  2011cited by this paper
• Clinical relevance of TNM staging system according to breast cancer subtypes.

  2011cited by this paper
• An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer

  2011cited by this paper
• Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)

  2011cited by this paper
• Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy

  2010cited by this paper
• FOXP3 expression and overall survival in breast cancer.

  2009cited by this paper
• CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.

  2009cited by this paper
• Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.

  2009cited by this paper
• Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma.

  2008cited by this paper
• Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target

  2008cited by this paper
• Infiltrating regulatory T cell numbers is not a factor to predict patient's survival in oesophageal squamous cell carcinoma

  2008cited by this paper
• Tregs and rethinking cancer immunotherapy.

  2007cited by this paper
• FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene.

  2007cited by this paper
• Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

  2007cited by this paper
• Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence

  2007cited by this paper
• Role of forkhead box protein 3 expression in invasive breast cancer.

  2007cited by this paper
• FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2.

  2007cited by this paper
• Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer.

  2007cited by this paper
• CD4+CD25+ Regulatory T-Cell Frequency in HER-2/neu (HER)-Positive and HER-Negative Advanced-Stage Breast Cancer Patients

  2007cited by this paper
• Prevalence of FOXP3+ Regulatory T Cells Increases During the Progression of Pancreatic Ductal Adenocarcinoma and Its Premalignant Lesions

  2006cited by this paper
• Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse.

  2006cited by this paper
• Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.

  2006cited by this paper
• FOXP3+ regulatory T cells: Current controversies and future perspectives

  2006cited by this paper
• Analysis of FOXP3 protein expression in human CD4(+)CD25(+) regulatory T cells at the single-cell level.

  2006cited by this paper
• REporting recommendations for tumor MARKer prognostic studies (REMARK)

  2005cited by this paper
• Global role of the immune system in identifying cancer initiation and limiting disease progression.

  2005cited by this paper
• Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single‐cell level

  2005cited by this paper
• Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

  2004cited by this paper
• Foxp3 Expressing CD4+CD25high Regulatory T Cells Are Overrepresented in Human Metastatic Melanoma Lymph Nodes and Inhibit the Function of Infiltrating T Cells1

  2004cited by this paper
• Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.

  2003cited by this paper
• Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.

  2003cited by this paper
• CD4+CD25high Regulatory Cells in Human Peripheral Blood1

  2001cited by this paper

• The likely possibility of predicting treatment outcomes of cervical lesions using serum FOXP3 and P16INK4A as shown by a cohort study in South Western Uganda.

  2026cites this paper
• Hallmarks of cancer in canine mammary tumors: Insights into a potential model for human triple-negative breast cancer.

  2026cites this paper
• Identification of M1 macrophage infiltration-related genes for immunotherapy in Her2-positive breast cancer based on bioinformatics analysis and machine learning

  2025cites this paper
• Triple Negative Breast Cancer Heterogeneity and Tumour Microenvironment- based Model Systems' Focus on Druggable Targets.

  2025cites this paper
• Effect modification between HLA-F and CD56 markers reveals differences in survival for triple-negative breast cancer patients.

  2024cites this paper
• Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review

  2024cites this paper
• Clinical and prognostic effects of microvascular density and FOXP3 positive T cells in breast cancer

  2024influential citation
• Detailed Profiling of the Tumor Microenvironment in Ethnic Breast Cancer, Using Tissue Microarrays and Multiplex Immunofluorescence

  2024cites this paper
• Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer

  2023cites this paper
• Implications of tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer: clinical oncologist perspectives

  2023cites this paper
• Metaplastic Carcinoma of the Axillary Breast With Heterologous Mesenchymal (Chondroid) Differentiation: A Difficult Case and Literature Review

  2023influential citation
• Investigating the Role of Tumor-Infiltrating Lymphocytes as Predictors of Lymph Node Metastasis in Deep Submucosal Invasive Colorectal Cancer: A Retrospective Cross-Sectional Study

  2023cites this paper
• Tumor Microenvironment Can Predict Chemotherapy Response of Patients with Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy

  2023cites this paper
• Expression of FOXP3 of Tumor-Infiltrating Lymphocytes in Invasive Breast Cancer: Its Relationship to Histopathological Parameters and Overall Survival

  2023cites this paper
• The prognostic values of FOXP3^+ tumor-infiltrating T cells in breast cancer: a systematic review and meta-analysis

  2023cites this paper
• Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer

  2022cites this paper
• Metformin Inducing the Change of Functional and Exhausted Phenotypic Tumor-Infiltrated Lymphocytes and the Correlation with JNK Signal Pathway in Triple-Negative Breast Cancer

  2022cites this paper
• Metformin Inducing the Change of Functional and Exhausted Phenotypic Tumor-Infiltrated Lymphocytes and the Correlation with JNK Signal Pathway in Triple-Negative Breast Cancer

  2022cites this paper
• Immunotherapy in triple-negative breast cancer: Insights into tumor immune landscape and therapeutic opportunities

  2022influential citation
• Overexpression of glucocorticoid receptor promotes the poor progression and induces cisplatin resistance through p38 MAP kinase in cervical cancer patients.

  2022cites this paper
• The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer

  2022cites this paper
• Combined Radionuclide Therapy and Immunotherapy for Treatment of Triple Negative Breast Cancer

  2021cites this paper
• Delineating the breast cancer immune microenvironment in the era of multiplex immunohistochemistry/immunofluorescence

  2021cites this paper
• Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Can Boost Immune Disruption

  2021cites this paper
• A Study on Tumor-Infiltrating Lymphocytes in Different Subtypes of Breast Cancer

  2021influential citation
• The role of FOXP3 of interstitial tissue in the pathogenesis of breast cancer

  2021cites this paper
• Prognostic and Clinicopathologic Associations of LAG-3 Expression in Triple-negative Breast Cancer

  2021cites this paper
• Regulatory T lymphocyte infiltration in metastatic breast cancer—an independent prognostic factor that changes with tumor progression

  2021cites this paper
• Clinical Relevance of the serum CTLA-4 in Cats with Mammary Carcinoma

  2020cites this paper
• Investigation of Intra-tumour Heterogeneity and Host Immune Response in Triple-negative Breast Cancer

  2020cites this paper
• Forkhead box P3 and indoleamine 2,3-dioxygenase co-expression in Pakistani triple negative breast cancer patients

  2020cites this paper
• The Multifaceted Role of Regulatory T Cells in Breast Cancer

  2020cites this paper
• The Tumor Microenvironment of Primitive and Metastatic Breast Cancer: Implications for Novel Therapeutic Strategies

  2020cites this paper
• Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

  2020cites this paper
• Immune microenvironment in different molecular subtypes of ductal breast carcinoma

  2020cites this paper
• Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1

  2020cites this paper
• Prognostic Role of Immune Markers in Triple Negative Breast Carcinoma

  2020cites this paper
• TNFR2+ TILs are significantly associated with improved survival in triple-negative breast cancer patients

  2020cites this paper
• Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer

  2020cites this paper
• Pseudo-CT Generation for External Radiotherapy Planning from Magnetic Resonance Imaging Data on Brain Regions

  2019cites this paper
• The predictive and prognostic value of Foxp3+/CD25+ regulatory T cells and PD-L1 expression in triple negative breast cancer.

  2019cites this paper
• The Tolerogenic Function of Regulatory T Cells in Pregnancy and Cancer

  2019cites this paper
• Immune Profiles of Tumor Microenvironment and Clinical Prognosis among Women with Triple-Negative Breast Cancer

  2019influential citation
• Efficacy analysis of triple-negative breast cancer patients treated with dendritic cell-cytokine-induced killer cell immunotherapy

  2019cites this paper
• Synergistic association of FOXP3+ tumor infiltrating lymphocytes with CCL20 expressions with poor prognosis of primary breast cancer

  2019cites this paper
• The prognostic value of regulatory T cells infiltration in HER2-enriched breast cancer microenvironment

  2018cites this paper
• Analysis of Treg cell population in patients with breast cancer with respect to progesterone receptor status

  2018cites this paper
• Standardized assessment of tumor-infiltrating lymphocytes in breast cancer: an evaluation of inter-observer agreement between pathologists

  2018influential citation
• CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer

  2018cites this paper
• Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early‐stage breast cancer patients treated with anthracycline‐based adjuvant chemotherapy

  2018cites this paper
• Predictive value of improvement in the immune tumour microenvironment in patients with breast cancer treated with neoadjuvant chemotherapy

  2018cites this paper
• Hormone and transcription factor regulation of cytokines in the mammary gland

  2018cites this paper
• Triple negative breast cancer – prognostic role of immune-related factors: a systematic review

  2018cites this paper
• First international TNBC conference meeting report

  2018cites this paper
• Characteristics and prognosis of breast cancer after liver or kidney transplantation

  2017cites this paper
• Calycosin Inhibits the Migration and Invasion of Human Breast Cancer Cells by Down-Regulation of Foxp3 Expression

  2017cites this paper
• Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance

  2017cites this paper
• Prognostic value of tumor-infiltrating Foxp3+ regulatory T cells in patients with breast cancer: a meta-analysis

  2017cites this paper
• The risk of breast cancer relapse depends both on tumor extent and biological Main immunoregulatory mechanisms that favor breast cancer development

  2017cites this paper
• How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment

  2017cites this paper
• High tumor-infiltrating FoxP3+ T cells predict poor survival in estrogen receptor-positive breast cancer: A meta-analysis.

  2017cites this paper
• Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy

  2017cites this paper
• Higher densities of Foxp3+ regulatory T cells are associated with better prognosis in triple-negative breast cancer

  2017cites this paper
• Regulatory T cells as suppressors of anti-tumor immunity: Role of metabolism.

  2017cites this paper
• [Main immunoregulatory mechanisms that favor breast cancer development].

  2017cites this paper
• The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis

  2016cites this paper
• Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ Tregs.

  2016cites this paper
• A prognostic risk model for patients with triple negative breast cancer based on stromal natural killer cells, tumor‐associated macrophages and growth‐arrest specific protein 6

  2016cites this paper
• Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+ Tregs : a systematic review and meta-analysis

  2016cites this paper
• Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in Breast Cancer

  2016cites this paper
• Tumor-Infiltrating Lymphocytes and Breast Cancer: Are Immune Checkpoint Inhibitors Ready for Prime Time in Breast Cancer?

  2016cites this paper
• CD44 induces FOXP3 expression and is related with favorable outcome in breast carcinoma

  2016cites this paper
• Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication

  2016cites this paper
• Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer

  2016cites this paper
• The prognostic value of peripheral CD4+CD25+ T lymphocytes among early stage and triple negative breast cancer patients receiving dendritic cells-cytokine induced killer cells infusion

  2015cites this paper
• Targeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease.

  2015cites this paper
• Tumour-Infiltrating Lymphocytes (TILs) in Breast Cancer: a Predictive or a Prognostic Marker?

  2015cites this paper
• Immunology and Immunotherapy of Breast Cancer

  2015cites this paper
• Tumor-infiltrating lymphocytes in breast cancer: ready for prime time?

  2015influential citation
• Role of inflammatory infiltrates in triple negative breast cancer

  2015cites this paper
• Estudio de factores biológicos implicados en el pronóstico del cáncer de mama mediante meta-análisis de datos publicados

  2015cites this paper
• Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients

  2015cites this paper
• Clinicopathological and prognostic significance of FOXP3+ tumor infiltrating lymphocytes in patients with breast cancer: a meta-analysis

  2015influential citation
• Ferritin Expression in Breast Cancer Infiltrating Lymphocytes. Evaluation of Biological Significance and Modulation by HLA-A*03 and HFE

  2015influential citation
• Clinical Activity of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Post-Mastectomy Triple-Negative Breast Cancer

  2014cites this paper
• Dissecting the Regulatory Microenvironment of a Large Animal Model of Non-Hodgkin Lymphoma: Evidence of a Negative Prognostic Impact of FOXP3+ T Cells in Canine B Cell Lymphoma

  2014cites this paper
• A Role for T-Lymphocytes in Human Breast Cancer and in Canine Mammary Tumors

  2014cites this paper
• FOXP3 Transcription Factor: A Candidate Marker for Susceptibility and Prognosis in Triple Negative Breast Cancer

  2014cites this paper
• Cancer Therapy : Clinical Clinical Activity of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Post-Mastectomy Triple-Negative Breast Cancer

  2014cites this paper
• Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration

  2014cites this paper
• Molecular and clinicopathological markers of prognosis in breast cancer

  2013cites this paper
• Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs

  2013cites this paper